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Chronic respiratory disease (CRD) is caused by Mycoplasma gallisepticum (MG). 
Infected birds show respiratory and reproductive problems which lead to severe 
economic losses in poultry industry. There are only few published data on avian 
mycoplasmosis in Malaysia, thus, this study was carried out to determine the strain 
variability and pathogenicity of MG isolates, towards understanding the control of 
the infection. A total of 4605 samples were collected from chickens and their 
progeny from various commercial farms using sterile cotton swabs for culturing onto 
mycoplasma agar. Twenty three (23) MG isolates were obtained from suspected MG 
infected commercial chickens. Although MG could be isolated from various sites of 
the host, in this study, choanal and tracheal sites proved to be the best sites in live 
birds. On the other hand, trachea and airsac samples were the best sites for the 
detection of MG for chick embryos or chicks. Size variations among polymerase 
chain reaction products divergence of the MG-specific gene were the basis for strain 
differentiation. The local isolates exhibited gene size polymorphism in pvpA gene, 
16S-23S rRNA intergenic spacer region gene, ermA gene and pMGA or vlhA gene 
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with the presence of insertion or deletion observed in PCR products. However, the 
gapA gene, LP gene, F-strain-specific DNA fragment gene, CrmB gene, CrmC gene, 
p47 gene, HMW3-like protein gene and pneumoniae-like protein A gene sequences 
were constant in size. The embryonated eggs were each inoculated with 
"pleuropneumonia like organism" (PPLO) broth containing MG strains, via yolk sac. 
Mycoplasma gal/isepticum embryos, broth inoculated and uninoculated control 
embryonated eggs were examined at necropsy days 7, 10, 13 and 15 post-inoculation. 
The pathogenicity of the isolates in chicken embryonated eggs showed variations 
among each other. The MG isolates and strains that showed a wide variation in genes 
were examined for virulence in ovo. In this study, the presence of caseous airsac 
lesion correlated with virulence ofMG and presence of high maternal antibody titer. 
MG were isolated only in embryos that did not develop any caseous airsac lesions. 
MG inoculated embryos were polymerase chain reaction (PCR) positive regardless 
of the absence or presence of caseous airsac lesion, suggesting that caseous airsac 
lesion maybe the result of formation of antigen-antibody complex. Caseous airsacs 
were found to be one of the prominent lesions associated with MG infection. For 
certain highly pathogenic strains, there was clear relationship between the caseous 
airsac lesion and the presence of maternal antibody titer and embryo mortality. Less 
pathogenic strains that grow well usually caused embryo mortality during later stages 
of incubation and there was no strict correlation between caseous airsac lesion and 
the presence or absence of maternal antibody and embryo mortality. Based on the 
presence of the gene size polymorphism in pvpA gene and pMGA or vlhA gene; 
MGS6 (reference strain), 144 and 1-18 strains of MG showed a similar pattern of 
pathogenicity in that they are highly pathogenic, whereas, H21 8T, H21 lIT, H24 5C 
and H26 9C have similar pattern of molecular characterization and pathogenicity 
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with ts-l1 (vaccine strain), characterized by their less pathogenicity in embryos. 
MGS6, 144 and 1-18 strains caused early embryonic death compared to ts-11, H21 
8T, H2 1  lIT, H24 5C and H26 9C strains that caused embryo mortality during later 
stages of incubation. At this point, the postulation is that, when maternal antibody of 
MG is high and MG challenge is present, caseous airsac may occur. This would be 
due to maternal antibody in the eggs which may bind to MG that served as antigen to 
form antigen-antibody complexes. The immune complexes may help to release 
cytokines and attract more macrophages and other inflammatory cells, which help to 
increase the severity of the air sac lesion. When the MG strain with the gene size 
polymorphism in pvpA gene and pMGA or vlhA gene that has similar pattern with 
MGS6, it correlates with the formation of caseous air sac, as well as the increase in 
severity of the caseous airsac. This study showed that the combination of the gene 
size polymorphism in pvpA gene and pMGA or vlhA gene can be used as pathogenic 
markers for MG in determination of its pathogenicity towards chick embryos. Based 
on characterization and pathogenicity, MG field strains H2 1  8T, H21 HT, H24 5C 
and H26 9C showed similar pattern of molecular and pathogenicity characteristic 
with ts-l1 and therefore are potential candidates for live MG vaccine. 
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Penyakit pernafasan kronik (eRD) adalah disebabkan oleh Mycoplasma 
gallisepticum (MG). Ayam yang telah dijangkiti menunjukkan tanda-tanda masalah 
pemafasan dan reproduktif yang memberi kerugian yang besar pada industri ayam. 
Hanya sedikit data yang telah diterbitkan berkenaan dengan mycoplasmosis unggas 
di Malaysia. Oleh itu kajian ini dilakukan untuk mengenalpasti kebarangkalian 
variasi dan patogenik isolat-isolat MG ke arah memahami cara-cara mengawal 
jangkitan. Sebanyak 4605 sampel swab daripada ladang-ladang komersial dikultur ke 
dalam agar. Dua puluh tiga isolat MG telah berjaya diperoleh daripada ladang ayam 
komersial yang disyaki telah dijangkiti MG. Dalam kajian ini, choanal dan trakea 
merupakan bahagian yang terbaik untuk mendapatkan isolat MG dari unggas hidup, 
walaupun MG boleh didapati di pelbagai bahagian perumah. Bagi mengesan MG 
pada embrio ayam dan anak ayam, bahagian terbaik pula merupakan trakea dan 
katung pemafasan. Perbezaan saiz antara bahan hasil proses (polymerase chain 
reaction' di antara gen tertentu dalam MG adalah asas untuk pembezaan strain. Isolat 
tempatan mempamerkan polymorphism saiz gen bagi genpvpA, gen 16S-23S rRNA 
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intergenic spacer region, gen ermA dan gen pMGA atau vlhA dengan kehadiran 
insertion ataupun deletion yang dapat diperhatikan di dalam produk peR. 
Walaubagaimanapun, gen gapA, gen LP, gen F-strain-specifik DNA fragment, gen 
CrmB, gen CrmC, gen p47, gen HMW3-like protein dan gen pneumoniae-like 
protein A menunjukkan saiz yang konsistan. Setiap telur berembrio disuntik dengan 
"pleuropneumonia like organism" (PPLO) yang mengandungi MG strain melalui 
kantung kuning telur. Telur berembrio yang disuntik dengan Mycoplasma 
gallisepticum, telur dari kumpulan broth dan telur berembrio yang tidak disuntik, 
diperiksa semasa nekropsi pada hari 7, 10,13 dan 15 selepas hari suntikan. 
Patogenisiti isolat-isolat yang terdapat pada ernbrio ayam memparnerkan variasi 
antara satu sarna lain. Isolat-isolat dan strain MG yang menunjukkan variasi 
diperiksa patogenisitinya in ovo. Dalam kajian ini, kehadiran lesi kaseous katung 
pernafasan dikaitkan dengan patogenisiti MG dan kehadiran titer maternal antibodi 
yang tinggi. MG hidup hanya dapat dikultur dari embrio yang telah diinokulasi 
dengan MG dan tidak membentuk ataupun menghasilkan lesi kaseous katung 
pernafasan yang berskala satu. Embrio yang telah diiokulasi sarna ada dengan atau 
tiada penghasilan kaseous katung pernafasan memberikan keputusan PCR yang 
positif, menyarankan bahawa lesi kaseous katung pemafasan berkemungkinan 
terhasil daripada pembentukan komplek antigen-antibodi. Kaseous katung udara 
didapati rnerupakan lesi yang paling ketara dikaitkan dengan jangkitan MG. Bagi 
sebilangan strain yang arnat patogenik, terdapat hubungkait yang jelas di antara lesi 
kaseous katung pernafasan dan kehadiran titer rnatermal antibodi serta kernatian 
embrio. Strain-strain kurang patogenik yang tumbuh dengan baik biasanya 
menyebabkan kematian embrio pada peringkat akhir inkubasi dan tiada hubungkait 
yang jelas di antara lesi kaseous katung pernafasan dan kehadiran maternal antibodi 
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dan kematian embryio. Berpandukan kepada kehadiran polymorphism saiz gen pada 
gen pvpA dan gen pMGA atau vlhA, MGS6 (strain rujukan), 144 dan 1-18 
menunjukkan corak patogenisiti yang sama di mana kesemuanya adalah amat 
patogenik. Manakala ts-11 (strain vaksin), H21 8T, H21 11T, H24 5C dan H26 9C 
memiliki corak patogenisiti yang sarna dikategorikan oleh patogenisiti yang lebih 
rendah pada embrio. Strain-strain MGS6, 144 dan 1-18 menyebabkan kematian 
embrio pada awal inkubasi berbanding dengan strain-strain ts-l1, H21 8T, H21 lIT, 
H24 5C dan H26 9C pada peringkat-peringkat akhir inkubasi. Pada tahap ini, andaian 
yang dibuat ialah apabila maternal antibodi bagi MG tinggi dan dengan kehadiran 
MG, kaseous katung pernafasan mungkin berlaku. Ini disebabkan oleh maternal 
antibodi dalam telur yang mana boleh terikat pada MG yang bertindak sebagai 
antigen untuk membentuk antigen-antibodi kompleks. Kompleks imun boleh 
membantu untuk membebaskan sitokin dan menarik lebih makrofaj dan sel radang 
yang lain, yang mana membantu untuk meningkatkan tahap keterukan lesi katung 
pernafasan. Apabila strain MG yang memiliki polymorphism saiz gen pada gen-gen 
pvpA dan pMGA atau vlhA yang meyerupai dengan MGS6, ini akan berhubungkait 
dengan pembentukan kaseous katung pernafasan dan juga terlibat dengan 
peningkatan tahap severiti kaseous katung pernafasan. Kajian ini menunjukkan 
bahawa kombinasi polymorphism saiz gen-gen pvpA dan pMGA atau vlhA boleh 
digunakan sebagai penanda patogenik MG dalam penentuan patogenisitinya terhadap 
embrio ayam. Berdasarkan ciri-ciri gen dan patogenisiti, strain tempatan MG H21 
8T, H21 liT, H24 5C and H26 9C telah menunjukkan corak molekular dan ciri-ciri 
patogenisiti yang sarna dengan ts-l1 dan merupakan calon-calon yang berpotensi 
sebagai vaksin hidup MG. 
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